Mindray Medical International (MR) Tops Q1 EPS by 2c

Mindray Medical International (NYSE: MR) reported Q1 EPS of $0.39, $0.02 better than the analyst estimate of $0.37. Revenue for the quarter came in at $264.8 million versus the consensus estimate of $292.5 million.

For earnings history and earnings-related data on Mindray Medical International (MR) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight